These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 33691657)

  • 41. Radiomics analysis to predict pulmonary nodule malignancy using machine learning approaches.
    Warkentin MT; Al-Sawaihey H; Lam S; Liu G; Diergaarde B; Yuan JM; Wilson DO; Atkar-Khattra S; Grant B; Brhane Y; Khodayari-Moez E; Murison KR; Tammemagi MC; Campbell KR; Hung RJ
    Thorax; 2024 Mar; 79(4):307-315. PubMed ID: 38195644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).
    Liang W; Zhao Y; Huang W; Gao Y; Xu W; Tao J; Yang M; Li L; Ping W; Shen H; Fu X; Chen Z; Laird PW; Cai X; Fan JB; He J
    Theranostics; 2019; 9(7):2056-2070. PubMed ID: 31037156
    [No Abstract]   [Full Text] [Related]  

  • 43. The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders.
    Konecny M; Markus J; Waczulikova I; Dolesova L; Kozlova R; Repiska V; Novosadova H; Majer I
    Neoplasma; 2016; 63(2):246-53. PubMed ID: 26774146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. External validation of radiomics-based predictive models in low-dose CT screening for early lung cancer diagnosis.
    Garau N; Paganelli C; Summers P; Choi W; Alam S; Lu W; Fanciullo C; Bellomi M; Baroni G; Rampinelli C
    Med Phys; 2020 Sep; 47(9):4125-4136. PubMed ID: 32488865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benign-malignant classification of pulmonary nodules by low-dose spiral computerized tomography and clinical data with machine learning in opportunistic screening.
    Zheng Y; Dong J; Yang X; Shuai P; Li Y; Li H; Dong S; Gong Y; Liu M; Zeng Q
    Cancer Med; 2023 Jun; 12(11):12050-12064. PubMed ID: 37248730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial.
    Silvestri GA; Tanner NT; Kearney P; Vachani A; Massion PP; Porter A; Springmeyer SC; Fang KC; Midthun D; Mazzone PJ;
    Chest; 2018 Sep; 154(3):491-500. PubMed ID: 29496499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinoma.
    Zhao J; Lu Y; Ren X; Bian T; Feng J; Sun H; Liu L; She B; Liu Y; Ke H
    BMC Cancer; 2024 Jun; 24(1):687. PubMed ID: 38840077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative CT-based radiomics combined with intraoperative frozen section is predictive of invasive adenocarcinoma in pulmonary nodules: a multicenter study.
    Wu G; Woodruff HC; Sanduleanu S; Refaee T; Jochems A; Leijenaar R; Gietema H; Shen J; Wang R; Xiong J; Bian J; Wu J; Lambin P
    Eur Radiol; 2020 May; 30(5):2680-2691. PubMed ID: 32006165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Feasibility of lung cancer prediction from low-dose CT scan and smoking factors using causal models.
    Raghu VK; Zhao W; Pu J; Leader JK; Wang R; Herman J; Yuan JM; Benos PV; Wilson DO
    Thorax; 2019 Jul; 74(7):643-649. PubMed ID: 30862725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers.
    Shen J; Liu Z; Todd NW; Zhang H; Liao J; Yu L; Guarnera MA; Li R; Cai L; Zhan M; Jiang F
    BMC Cancer; 2011 Aug; 11():374. PubMed ID: 21864403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diagnostic Efficacy of SHOX2 Gene Hypermethylation for Lung Cancer: A Meta-Analysis].
    Liu Q; Wang S; Pei G; Yang Y; Huang Y
    Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):490-496. PubMed ID: 34275516
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis of pulmonary nodules by DNA methylation analysis in bronchoalveolar lavage fluids.
    Li L; Ye Z; Yang S; Yang H; Jin J; Zhu Y; Tao J; Chen S; Xu J; Liu Y; Liang W; Wang B; Yang M; Huang Q; Chen Z; Li W; Fan JB; Liu D
    Clin Epigenetics; 2021 Oct; 13(1):185. PubMed ID: 34620221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction.
    Sun Y; Li C; Jin L; Gao P; Zhao W; Ma W; Tan M; Wu W; Duan S; Shan Y; Li M
    Eur Radiol; 2020 Jul; 30(7):3650-3659. PubMed ID: 32162003
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction model for malignant pulmonary nodules based on cfMeDIP-seq and machine learning.
    Qi J; Hong B; Tao R; Sun R; Zhang H; Zhang X; Ji J; Wang S; Liu Y; Deng Q; Wang H; Zhao D; Nie J
    Cancer Sci; 2021 Sep; 112(9):3918-3923. PubMed ID: 34251068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules.
    Xing L; Su J; Guarnera MA; Zhang H; Cai L; Zhou R; Stass SA; Jiang F
    Clin Cancer Res; 2015 Jan; 21(2):484-9. PubMed ID: 25593345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development and validation of an integrated system for lung cancer screening and post-screening pulmonary nodules management: a proof-of-concept study (ASCEND-LUNG).
    Jin Y; Mu W; Shi Y; Qi Q; Wang W; He Y; Sun X; Yang B; Cui P; Li C; Liu F; Liu Y; Wang G; Zhao J; Zhang Y; Zhang S; Cao C; Sun C; Hong N; Cai S; Tian J; Yang F; Chen K
    EClinicalMedicine; 2024 Sep; 75():102769. PubMed ID: 39165498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benign pathologies results from lung nodule percutaneous biopsies: How to differentiate true and false benign?
    Li L; Xu XL; Feng K; Liu XQ; Yang J
    J Cancer Res Ther; 2021 Jul; 17(3):658-663. PubMed ID: 34269296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Precision patient selection for improved detection of circulating genetically abnormal cells in pulmonary nodules.
    Tu M; Wang X; Liu H; Jia H; Wang Y; Li J; Zhang G
    Sci Rep; 2024 Sep; 14(1):22532. PubMed ID: 39341939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Localized thin-section CT with radiomics feature extraction and machine learning to classify early-detected pulmonary nodules from lung cancer screening.
    Tu SJ; Wang CW; Pan KT; Wu YC; Wu CT
    Phys Med Biol; 2018 Mar; 63(6):065005. PubMed ID: 29446758
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules.
    Yang H; Chen H; Zhang G; Li H; Ni R; Yu Y; Zhang Y; Wu Y; Liu H
    BMC Cancer; 2022 Apr; 22(1):382. PubMed ID: 35397524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.